Introducing the #FellowsForum! Register today to join our exclusive online community for #hematology/#oncology #fellows. Learn more and register here! @SamuelKareffMD @WaqasHaqueMD @RichaThakurMD @TanejaMD @NidaKhanMD @HemOncFellows @RahulBanerjeeMD

Our #Fellow of the Month for February is Wint Yan (Arthur) Aung, MD, a first-year #HemeOnc Fellow at @ZuckerSoM at @NorthwellHealth! He tells us about his passion for research and patient care, and what he loves most about being a fellow. Watch here!

#WorldCancerDay is a time to emphasize person-centered #supportive #cancer care. In this video, Daneen Sekoni, VP, Policy and Advocacy @CancerSupportHQ, introduces #TogetherForSupportiveCancerCare and how it empowers patients and caregivers. Watch here!

In this edition of his #FellowsForum Blog, @WaqasHaqueMD explores the new frontier of AI for #ClinicalTrial matching, including innovations streamlining complex processes with near-human accuracy while democratizing access to lifesaving trials. Read here!

In this interview, Dr. @GuyYoungMD updates us on the latest #advancements in the #treatment and management of #hemophilia since co-chairing the #CME/#NCPD-accredited activity with @i3health. Listen along and check out the complete activity here:

This #FellowsFriday, we're welcoming a new member of the #FellowsForum! Shannon McGue, MD, @DukeCancer To learn more about the Fellows Forum, including how to join the community and hear about upcoming programs, visit #Fellowship #HemOncFellowship

Today's #FellowsFriday quote comes from @HundalJasmin during her interview with @imaurer at #SABCS24. Listen to the podcast to hear their full conversation about #AI in #oncology! And learn more about joining the Fellows Forum at:

Recently, @i3health provided an #educational opportunity that challenged nurses’ #proficiency for the management of immune-related adverse events (#IRAEs). Check out the activity #outcomes and what was learned here:

At #SABCS24, #FellowsForum member @HundalJasmin sat down for an interview with @imaurer, Chief Technology Officer at @GenomOncology, to explore the uses, challenges, and future directions of #AI in #precision #oncology. Listen here! @SABCSSanAntonio

The @ASH_hematology Trainee Council is a network dedicated to career development for #hematology #residents and #fellows. Here, current and past Chairs, Kaitlyn Dykes, @HemUcsd, and Maya Abdallah, @The_BMC, share more about it. Watch here! #ASH24

The #FDA has granted approval to #acalabrutinib with bendamustine and rituximab for adults with previously untreated mantle cell #lymphoma (#MCL). Read more about the #ECHO trial that led to the #approval here:

Today's #FellowsFriday comes from @sheeba_baaqeel, Hematologist/Oncologist at @BayhealthDE, from our recent Q&A session for graduating #fellows on navigating their first #job search. Visit the #FellowsForum to join the community and receive more insights!

In this episode, @WaqasHaqueMD talks with Kristin Maloney, Clinical Informatics Lead at @mendel_ai_ about their #AI platform that leverages physician-level cognitive capabilities to enhance data processing and improve clinical decision making. Watch here!

In this #ClinicConversation, @HundalJasmin (@ClevelandClinic) explores the #EMBER3 trial of #imlunestrant for ER-positive, HER2-negative advanced #BreastCancer, including results from #SABCS24 and how to discuss imlunestrant with patients. Read here!

At #SABCS24, Dr. Erica Fortune, VP of Research at @CancerSupportHQ, presented the team's findings on the relationship between treatment #adherence, #tolerability, and patient experiences in #BreastCancer. Learn more in the video! #bcsm @SABCSSanAntonio

Today's #FellowsFriday comes from @richardriedelmd, Fellowship Program Director at @DukeMedSchool, who shared his insights for #residents applying for #HemeOnc #fellowship during our recent Q&A. Visit the #FellowsForum to learn more about future sessions!

At #ASH24, Catherine Forbes of @RoswellPark presented how social determinants of #health (#SDOH) impact survival outcomes in patients with multiple #myeloma. Learn more about her presentation and the #outcomes she presented here:

What do oncologists and mathletes have in common in 2025? In this Letter from the Editor, OncData Editor in Chief @RahulBanerjeeMD explores how the “prime factors” of oncology drive healthcare quality and shape the future of cancer care. Read it here!

In this week's #ClinicConversation, @WaqasHaqueMD discusses the trial investigating #ponsegromab for the treatment of cancer #cachexia and the importance of addressing #weight and #appetite loss in the context of comprehensive cancer care. Watch here!

At #ASH24, Dr. @Matt_Cortese of @RoswellPark presented groundbreaking research on the effects of #venetoclax on immune function in #CLL and its potential to repair immune deficiencies and pave the way for effective combination therapies. Learn more here!

#Cosibelimab, a novel #PD1 inhibitor, has received #FDA approval for unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma (#CSCC), offering a new option for patients. Learn more in this video from Dr. Matt Hadfield: